Contemporary overview of metallo-Β-lactamases in pseudomonas aeruginosa: Epidemiology, detection methods and treatment challenges

Página do item simplificado
dc.contributor.authorCamargo, Carlos Henrique [UNESP]
dc.contributor.authorBruder-Nascimento, Ariane [UNESP]
dc.contributor.authorMondelli, Alessandro Lia [UNESP]
dc.contributor.authorMontelli, Augusto Cezar [UNESP]
dc.contributor.authorSadatsune, Terue [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-29T07:13:21Z
dc.date.available2022-04-29T07:13:21Z
dc.date.issued2012-11-01
dc.description.abstractAntimicrobial resistance poses a daunting challenge to treating bacterial infections. In Pseudomonas aeruginosa, an important opportunistic agent of nosocomial infection, antimicrobial resistance is well-pronounced and can be due to several intrinsic or acquired mechanisms. The therapeutic options to treat P. aeruginosa infection vary according to antimicrobial resistant patterns. Carbapenems, which had been longstanding last-line agents for treating P. aeruginosa infections, have become almost ineffective against this agent, mainly due to the emergence of carbapenemases. Metallo-ß-lactamases (MBL), enzymes from Bush and Jacoby's Group 3, are able to hydrolyze several substrates, such as carbapenems and cephalosporins. The genes encoding these enzymes are essentially located on mobile genetic elements that may be transferable to other strains or even distinct species. Considering their ubiquitous nature and potential to survive in hospital environments, early detection and implementation of contention barriers are desirable to prevent this bacterium from spreading throughout hospital settings and to prescribe a rational antibiotic regimen. Thus, fast and specific tests to detect MBL-producing P. aeruginosa are important both for bedside clinicians and hospital infection control committees. The purpose of this text is to provide an overview on the current status of the epidemiology, detection methods and treatment options for MBL-producing P. aeruginosa infections. © 2012 by Nova Science Publishers, Inc. All rights reserved.en
dc.description.affiliationDepartment of Microbiology and Immunology Botucatu Biosciences Institute UNESP - Univ Estadual Paulista, Botucatu, São Paulo State
dc.description.affiliationDepartment of Internal Medicine Botucatu Medical School UNESP - Univ Estadual Paulista, Botucatu, São Paulo State
dc.description.affiliationUnespDepartment of Microbiology and Immunology Botucatu Biosciences Institute UNESP - Univ Estadual Paulista, Botucatu, São Paulo State
dc.description.affiliationUnespDepartment of Internal Medicine Botucatu Medical School UNESP - Univ Estadual Paulista, Botucatu, São Paulo State
dc.format.extent101-124
dc.identifier.citationPseudomonas Aeruginosa: Symptoms of Infection, Antibiotic Resistance and Treatment, p. 101-124.
dc.identifier.scopus2-s2.0-84892209725
dc.identifier.urihttp://hdl.handle.net/11449/227455
dc.language.isoeng
dc.relation.ispartofPseudomonas Aeruginosa: Symptoms of Infection, Antibiotic Resistance and Treatment
dc.sourceScopus
dc.titleContemporary overview of metallo-Β-lactamases in pseudomonas aeruginosa: Epidemiology, detection methods and treatment challengesen
dc.typeCapítulo de livro
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos

Coleções

Artigos - Microbiologia e Imunologia - IBB
Botucatu - FMB - Faculdade de Medicina